Aberdeen Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.4M | Buy |
|
|||||
|
2025
Q2 | $14.4M | Buy |
|
|||||
|
2025
Q1 | $14M | Sell |
|
|||||
|
2024
Q4 | $55.6M | Sell |
|
|||||
|
2024
Q3 | $53.1M | Sell |
|
|||||
|
2024
Q2 | $62M | Sell |
|
|||||
|
2024
Q1 | $74.9M | Buy |
|
|||||
|
2023
Q4 | $64.1M | Buy |
|
|||||
|
2023
Q3 | $53.6M | Sell |
|
|||||
|
2023
Q2 | $146M | Sell |
|
|||||
|
2023
Q1 | $138M | Sell |
|
|||||
|
2022
Q4 | $96.1M | Buy |
|
|||||
|
2022
Q3 | $98.3M | Buy |
|
|||||
|
2022
Q2 | $91.1M | Buy |
|
|||||
|
2022
Q1 | $118M | Buy |
|
|||||
|
2021
Q4 | $126M | Buy |
|
|||||
|
2021
Q3 | $114M | Sell |
|
|||||
|
2021
Q2 | $95.4M | Sell |
|
|||||
|
2021
Q1 | $75.3M | Sell |
|
|||||
|
2020
Q4 | $76.4M | Sell |
|
|||||
|
2020
Q3 | $76.6M | Buy |
|
|||||
|
2020
Q2 | $62.2M | Buy |
|
|||||
|
2020
Q1 | $28.3M | Buy |
|
|||||
|
2019
Q4 | $1.11M | Buy |
|